That's pretty much what it says they might get a partner to help market Aldox for STS indications before late 2018 approval. As it is planned in Q3 this year.
It is surprising no mention of SCLC anymore. This would confirm the talk that the company is under confidential agreements with one or more party.
We're either going to be winning big soon, or lose big. But, I like the odds here based on what I am seeing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.